ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.
Products, services, technology
Products: antibodies, Analytical Services, Recombinant Proteins, Assay Kits
Custom Development Services: Proteins, Antibodies, GMP, etc.
Core Technology: Complex Native Structure Platform, AI-based Protein Expression Platform, Protein Labeling Platform, Protein Purification Platform, etc.
In order to support the development of target therapeutics, vaccines, and diagnostic solutions, we strive to continuously innovate while focusing on quality and performance to offer better solutions to our customers.
Our people are what make us an industry-leading company. We believe in the power of science to revolutionize global health. This means that we are dedicated to our mission of delivering the world’s highest quality research products that accelerate the development of ground-breaking therapies.
Our global presence enables us to cultivate our network of industry professionals and experts while providing our customers with the services, resources, and channels to succeed.